Alcon (ALCE) Stock Overview

Researches, develops, manufactures, distributes, and sells eye care products worldwide. More details

ALCE fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	3/6
Past Performance	2/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 44.2% below our estimate of its fair value

Earnings are forecast to grow 18.14% per year

Risk Analysis

Profit margins (7.7%) are lower than last year (11.3%)

ALCE Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Alcon Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Alcon
Historical stock prices
Current Share Price	CHF 53.64
52 Week High	CHF 54.54
52 Week Low	CHF 48.16
Beta	0.70
1 Month Change	0.64%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	6.26%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	ALCE	CH Medical Equipment	CH Market
7D	1.6%	1.8%	0.9%
1Y	n/a	-15.6%	15.2%

Return vs Industry: Insufficient data to determine how ALCE performed against the Swiss Medical Equipment industry.

Return vs Market: Insufficient data to determine how ALCE performed against the Swiss Market.

Price Volatility

Is ALCE's price volatile compared to industry and market?
ALCE volatility
ALCE Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	4.2%
Market Average Movement	4.3%
10% most volatile stocks in CH Market	7.5%
10% least volatile stocks in CH Market	2.2%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine ALCE's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1945	25,000	David Endicott	www.alcon.com

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.

Alcon Inc. Fundamentals Summary

How do Alcon's earnings and revenue compare to its market cap?
ALCE fundamental statistics
Market cap	CHF 25.74b
Earnings (TTM)	CHF 663.43m
Revenue (TTM)	CHF 8.61b

39.2x

P/E Ratio

3.0x

P/S Ratio

Is ALCE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALCE income statement (TTM)
Revenue	US$10.63b
Cost of Revenue	US$4.66b
Gross Profit	US$5.97b
Other Expenses	US$5.15b
Earnings	US$819.00m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

Aug 11, 2026

Earnings per share (EPS)	1.68
Gross Margin	56.14%
Net Profit Margin	7.70%
Debt/Equity Ratio	21.4%

How did ALCE perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

21%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/23 20:41
End of Day Share Price	2026/06/23 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alcon Inc. is covered by 58 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
null null	Argus Research Company
null null	Baird
Jeffrey Johnson	Baird